The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Amlodipine/Valsartan Krka 5 mg/ 80 mg film-coated tablets

5 mg/80 milligram(s) Film-coated tablet

Krka d.d., Novo mestoPA1347/055/001

Main Information

Trade NameAmlodipine/Valsartan Krka 5 mg/ 80 mg film-coated tablets
Active SubstancesValsartan
Amlodipine as amlodipine besilate
Strength5 mg/80 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/055/001

Group Information

ATC CodeC10BX HMG CoA reductase inhibitors, other combinations
C10BX09 ZZZ rosuvastatin and amlodipine


Licence Issued05/02/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0042-087-003
Interchangeable List DocumentPDF of Interchangeable List
« Back